Institutional Knowledge Map (KMap)
Map
Services
How To Use
About
Toggle theme
Loading...
Menu
Fernanda Sanchez Borchardt
Business Administrator
Social & Behavioral Sci Admin
Map Page
Research Area
oncology,
clinical trial,
chemotherapy,
solid tumors,
dose escalation,
cancer immunotherapy,
metastatic breast cancer,
immunotherapy combinations,
hormone therapy resistance
Grants
(2)
A Phase 1/2, Open Label, Dose-Escalation Study Of Oral ORIN1001 With And Without Chemotherapy In The Treatment Of Subjects With Solid Tumors
Active
·
2022
·
$0 / $245.9K
·
External
oncology,
clinical trial,
chemotherapy,
solid tumors,
dose escalation
A Multicenter, Open-label, Phase 2 Study of Imprime PGG and Pembrolizumab in Patients with Metastatic Breast Cancer (mBCA) Who Have Progressed Through Prior Hormonal Therapy
Active
·
2022
·
$0 / $185.5K
·
External
cancer immunotherapy,
metastatic breast cancer,
immunotherapy combinations,
hormone therapy resistance
Collaborations
(3)
Carolyn Lane
Mutual work: 4 Proposals﹒2 Grants
Collaboration Details
Niyuri Fleming
Mutual work: 4 Proposals﹒2 Grants
Collaboration Details
Sylvia DeCero
Mutual work: 2 Grants﹒3 Proposals
Collaboration Details
$0 / $431.4K Funding
